Article Details

Lyndra Therapeutics Presents Promising Phase 2 Data on Once-Weekly Oral Risperidone ...

Retrieved on: 2021-04-18 20:15:00

Tags for this article:

Click the tags to see associated articles and topics

Lyndra Therapeutics Presents Promising Phase 2 Data on Once-Weekly Oral Risperidone .... View article details on hiswai:

Excerpt

Lyndra Therapeutics, a clinical-stage biotechnology company working to make daily pills a thing of the past, today announced results from its Phase 2 ...

Article found on: www.valdostadailytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up